Researchers evaluate the efficacy of FRO, a formula composed of fermented Rhus verniciflua Stokes and Orostachys japonicus, against acne pathogenesis via antimicrobial assessment and an in vitro analysis. FRO was found to contain phenolics such as gallic acid, fisetin, quercetin, and kaempferol and was determined to alleviate acne by inhibiting the growth of Cutibacterium acnes, inflammation, and excess sebum.
FDA breakthrough device decisions rebound after recent declines
The Food and Drug Administration designated 166 products under its breakthrough devices program in its most recent financial year, reversing the downward trend seen as
November 14, 2024